|
|
| Drugs of Abuse Screen | ||
| Order Code: DAUPOC
Order Form: A-1a Miscellaneous Request or IPR Req |
Hematology 6240 RCP 356-3527 |
|
Specimen |
Urine | ||
Collection Medium: |
| ||
Minimum: |
10 mls random urine | ||
Testing Schedule: |
24 hrs/day, 7 days a week, including holidays. | ||
Analytic Time: |
2 hours (upon receipt in laboratory) | ||
Reference Range: |
None | ||
Comments: |
Screen includes amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, phencyclidine, opiates, tetrahydrocannabinoids (THC) and urinary tricyclic antidepressants. A positive result for any of the tested drugs indicates the presence of the drug or metabolites in the urine, but does not measure the level of intoxication. If confirmation is needed for amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, phencyclidine, opiates, and tetrahydrocannabinoids (THC), call the Laboratory 356-3527. Allow up to seven days for confirmatory results. Confirmation is at an additional charge. Suggested confirmation of urinary tricyclic antidepressants is by the serum tricyclic antidepresssant screen test performed by Clinical Chemistry. See additional confirmation information at the links below. Test Cut-off Concentrations (ng/ml) Amphetamines 1000 Methamphetamines 1000 Barbiturates 300 Benzodiazepine 300 Cocaine 300 Opiate 300 Phencyclidine 25 Tricyclic antidepressants 1000 THC 50 References: Belson MG, Simon HK, Sullivan K, Geller RJ. The Utility of Toxicologic Analysis in Children with Suspected Ingestion. Pediatr Emerg Care 1999;15:383-387. Bast RP, Helmer SD, Henderson SR, Rogers MA, Shapiro WM, Smith RS. Limited Utility of Routine Drug Screening in Trauma Patients. South Med J 2000;93:397-399. De La Torre R, Domino-Salvany A, Badia R, Gonzalez G, McFarlane D, San L, Torrens M. Clinical Evaluation of the Triage Analytical Device for Drugs-of-Abuse Testing. Clinical Chemistry 1996;42(9):1433-1438. Hammett-Stabler CA, Pesce AJ, Cannon DJ. Urine Drug Screening in the Medical Setting. Clinica Chimica Acta 2002;315:125-135. Schiller MJ, Shumway M, Batki SL. Utility of Routine Drug Screening in a Psychiatric Emergency Setting. Psychiatric Services 2000;51:474-478. Sugarman JM, Rodgers GC, Paul RI. Utility of Toxicology Screening in a Pediatric Emergency Department. Pediatric Emergency Care. Pediatric Emergency Care 1997;13(3):194-197. | ||
Test Limitations: |
There is the possibility that other substances and/or factors may interfere with the test and cause erroneous results (e.g., technical or procedural errors). Call the lab at 319-356-3527 for additional information. See appendix "Cross Reacting Drugs". | ||
Methodology: |
Triage TOX Drug screen is a competitive fluorescence immunoassay used for the qualitative determination of nine common drugs of abuse in urine specimens. | ||
CPT Code: |
80101 x9 | ||
See also: Barbiturate Confirmation, Urine Benzodiazepine Confirmation, Urine Cocaine Confirmation, Urine Drugs of Abuse Screen Confirmation, Urine Opiate Confirmation, Urine Phencyclidine (PCP), Confirmation, Quantitative, Urine THC Confirmation, Urine Tricyclic Antidepressant Toxicology Screen (TCA), Serum | |||
See Additional Information: Cross Reacting Drugs |
Updated: 02/13/2007
Note: The information contained in this handbook is for use by personnel of University of Iowa Health Care. No other use is implied or intended.